Worldwide Healthcare Trust PLC - Annual Financial Report PR Newswire LONDON, United Kingdom, June 11 10 June 2025Worldwide Healthcare Trust PLC(the "Company") Annual Financial ...

With the U.S. FDA’s approval of Enflonsia (cesrovimab) to prevent respiratory syncytial virus (RSV) infection lower ...

The Scorpion Therapeutics spinoff sold rights for two EGFR inhibitors to Pierre Fabre Laboratories and is hoping to become a clinical-stage firm by 2026.

Nvidia (NASDAQ: NVDA) stock rose 0.3% and Hewlett Packard Enterprise (NYSE: HPE) rose 1.2% after the tech companies said they ...

Merck (MRK) stock is in focus as its Enflonsia RSV shot is cleared for infants in the U.S. in a market led by Sanofi (SNY) ...

On the currency front, sterling weakened as Bank of England easing bets rose following the release of the latest UK labor ...

With precious little to report out of Sino-U.S. trade talks in London, investors are ready to pounce on almost any sign a ...

Merck’s shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.

The latest poll showed less than 30% of CEOs expected some sort of recession or slowdown over the next six months.

Ochre Bio, based in Oxford, has appointed Dr Elaine Sullivan as a senior independent non-executive director. Dr Sullivan said: "I look forward to supporting Ochre Bio’s development as the company ...